Monte Rosa Therapeutics (GLUE) Non Operating Income (2020 - 2026)
Monte Rosa Therapeutics (GLUE) reported Non Operating Income of $5.94 million for Q2 2026, up 33.3% from $4.46 million a year earlier and up 6.4% from the prior quarter.
Monte Rosa Therapeutics (GLUE) Non Operating Income (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Monte Rosa Therapeutics' Non Operating Income came in at $17.88 million, up 32.8% year-over-year; for FY2025, it was $14.49 million, up 31.9% from FY2024.
- Non Operating Income has increased for three consecutive years.
- By year, Non Operating Income came in at $10.98 million in FY2024 (+32.4%), $8.3 million in FY2023 (+113.7%), $3.88 million in FY2022 and -$1.08 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Income in data going back to Q2 2020.
- Year over year, Non Operating Income has now increased in each of the last three quarters, with growth averaging 37.8% over the last eight quarters.
- The high point for year-over-year Non Operating Income in five years was Q1 2023 (growth of 500.3%); the low point was Q4 2023 (a decline of 6.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.58 million (Q1 2026), $3.64 million (Q4 2025) and $2.72 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Monte Rosa Therapeutics | 1.02 Bn | 428.56 Mn | - | 5.94 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.94 Mn |
| Mar 31, 2026 | 5.58 Mn |
| Dec 31, 2025 | 3.64 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 3.06 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 762,000.00 |
| Mar 31, 2022 | 370,000.00 |
| Dec 31, 2021 | -53,000.00 |
| Sep 30, 2021 | 31,000.00 |
Monte Rosa Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=GLUE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();